 | • レポートコード：QFJ1-3960 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、120ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、がん腫瘍プロファイリングの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（次世代シーケンシング（NGS）、ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、インサイツハイブリダイゼーション（ISH）、マイクロアレイ、その他）、用途別市場規模（個別化医療、診断、バイオマーカー発見、予後、研究用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・がん腫瘍プロファイリングの市場動向 ・企業の競争状況、市場シェア ・がん腫瘍プロファイリングの種類別市場規模と予測2016-2027（次世代シーケンシング（NGS）、ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、インサイツハイブリダイゼーション（ISH）、マイクロアレイ、その他） ・がん腫瘍プロファイリングの用途別市場規模と予測2016-2027（個別化医療、診断、バイオマーカー発見、予後、研究用） ・がん腫瘍プロファイリングの北米市場規模2016-2027（アメリカ、カナダ） ・がん腫瘍プロファイリングの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん腫瘍プロファイリングのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん腫瘍プロファイリングの中南米市場規模2016-2027（メキシコ、ブラジル） ・がん腫瘍プロファイリングの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Qiagen N.V.、Roche Molecular Systems Inc.、Abott Molecular、Illumina Inc.、NeoGenomics Laboratories、HTG Molecular Diagnostic、Genomic Health Inc.、Hologic Gen-Probe、BD Biosciences、Siemens Healthineers、Claris Life Sciences、Personal Genome Diagnostics, Inc.、Perthera, Inc.、Foundation Medicine, Inc、V., Strand、ApoCell、Contextual Genomics、Agendia、GenScript） ・結論 |
Cancer/tumor profiling provides information about the genes causing cancer, which would offer useful insights related to the mechanism of cancer. The potential of cancer profiling is not only limited to common cancers, such as lymphoma and breast cancer, but also is useful in molecular profiling of lung cancer, prostate cancer, and acute leukemia. Cancer profiling has plays a vital role in diagnosis at the molecular level, as better understanding of the cancer tumors helps physicians to make appropriate therapeutic decisions and avoid “over-treatment” of the cancer patients.
The global market is driven by growing demand for cancer profiling method by oncologists to diagnose or treat cancers as well as predict response to targeted therapy. In addition, rise in adoption of cancer biomarkers for tumor profiling, increase in incidence of cancer across the globe, and growth in use of next-generation sequencing technique for cancer profiling boost the market growth. However, high monetary investments for the development of biomarkers and dearth of skilled professionals or oncologists specific to tumor profiling hamper the market growth.
Market Analysis and Insights: Global Cancer Tumor Profiling Market
The global Cancer Tumor Profiling market size is projected to reach US$ 81350 million by 2027, from US$ 39410 million in 2020, at a CAGR of 10.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Tumor Profiling market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Tumor Profiling market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Tumor Profiling market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Tumor Profiling market.
Global Cancer Tumor Profiling Scope and Market Size
Cancer Tumor Profiling market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Tumor Profiling market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Next-generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Microarray
Others
Segment by Application
Personalized Medicine
Diagnostics
Biomarker Discovery
Prognostics
Research Applications
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Qiagen N.V.
Roche Molecular Systems Inc.
Abott Molecular
Illumina Inc.
NeoGenomics Laboratories
HTG Molecular Diagnostic
Genomic Health Inc.
Hologic Gen-Probe
BD Biosciences
Siemens Healthineers
Claris Life Sciences
Personal Genome Diagnostics, Inc.
Perthera, Inc.
Foundation Medicine, Inc
V., Strand
ApoCell
Contextual Genomics
Agendia
GenScript
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Tumor Profiling Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Next-generation Sequencing (NGS)
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Immunohistochemistry (IHC)
1.2.5 In Situ Hybridization (ISH)
1.2.6 Microarray
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cancer Tumor Profiling Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Personalized Medicine
1.3.3 Diagnostics
1.3.4 Biomarker Discovery
1.3.5 Prognostics
1.3.6 Research Applications
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Tumor Profiling Market Perspective (2016-2027)
2.2 Cancer Tumor Profiling Growth Trends by Regions
2.2.1 Cancer Tumor Profiling Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Tumor Profiling Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Tumor Profiling Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Tumor Profiling Industry Dynamic
2.3.1 Cancer Tumor Profiling Market Trends
2.3.2 Cancer Tumor Profiling Market Drivers
2.3.3 Cancer Tumor Profiling Market Challenges
2.3.4 Cancer Tumor Profiling Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Tumor Profiling Players by Revenue
3.1.1 Global Top Cancer Tumor Profiling Players by Revenue (2016-2021)
3.1.2 Global Cancer Tumor Profiling Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Tumor Profiling Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Tumor Profiling Revenue
3.4 Global Cancer Tumor Profiling Market Concentration Ratio
3.4.1 Global Cancer Tumor Profiling Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Tumor Profiling Revenue in 2020
3.5 Cancer Tumor Profiling Key Players Head office and Area Served
3.6 Key Players Cancer Tumor Profiling Product Solution and Service
3.7 Date of Enter into Cancer Tumor Profiling Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Tumor Profiling Breakdown Data by Type
4.1 Global Cancer Tumor Profiling Historic Market Size by Type (2016-2021)
4.2 Global Cancer Tumor Profiling Forecasted Market Size by Type (2022-2027)
5 Cancer Tumor Profiling Breakdown Data by Application
5.1 Global Cancer Tumor Profiling Historic Market Size by Application (2016-2021)
5.2 Global Cancer Tumor Profiling Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Tumor Profiling Market Size (2016-2027)
6.2 North America Cancer Tumor Profiling Market Size by Type
6.2.1 North America Cancer Tumor Profiling Market Size by Type (2016-2021)
6.2.2 North America Cancer Tumor Profiling Market Size by Type (2022-2027)
6.2.3 North America Cancer Tumor Profiling Market Size by Type (2016-2027)
6.3 North America Cancer Tumor Profiling Market Size by Application
6.3.1 North America Cancer Tumor Profiling Market Size by Application (2016-2021)
6.3.2 North America Cancer Tumor Profiling Market Size by Application (2022-2027)
6.3.3 North America Cancer Tumor Profiling Market Size by Application (2016-2027)
6.4 North America Cancer Tumor Profiling Market Size by Country
6.4.1 North America Cancer Tumor Profiling Market Size by Country (2016-2021)
6.4.2 North America Cancer Tumor Profiling Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cancer Tumor Profiling Market Size (2016-2027)
7.2 Europe Cancer Tumor Profiling Market Size by Type
7.2.1 Europe Cancer Tumor Profiling Market Size by Type (2016-2021)
7.2.2 Europe Cancer Tumor Profiling Market Size by Type (2022-2027)
7.2.3 Europe Cancer Tumor Profiling Market Size by Type (2016-2027)
7.3 Europe Cancer Tumor Profiling Market Size by Application
7.3.1 Europe Cancer Tumor Profiling Market Size by Application (2016-2021)
7.3.2 Europe Cancer Tumor Profiling Market Size by Application (2022-2027)
7.3.3 Europe Cancer Tumor Profiling Market Size by Application (2016-2027)
7.4 Europe Cancer Tumor Profiling Market Size by Country
7.4.1 Europe Cancer Tumor Profiling Market Size by Country (2016-2021)
7.4.2 Europe Cancer Tumor Profiling Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Tumor Profiling Market Size (2016-2027)
8.2 Asia-Pacific Cancer Tumor Profiling Market Size by Type
8.2.1 Asia-Pacific Cancer Tumor Profiling Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Tumor Profiling Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Tumor Profiling Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Tumor Profiling Market Size by Application
8.3.1 Asia-Pacific Cancer Tumor Profiling Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Tumor Profiling Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Tumor Profiling Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Tumor Profiling Market Size by Region
8.4.1 Asia-Pacific Cancer Tumor Profiling Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Tumor Profiling Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Tumor Profiling Market Size (2016-2027)
9.2 Latin America Cancer Tumor Profiling Market Size by Type
9.2.1 Latin America Cancer Tumor Profiling Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Tumor Profiling Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Tumor Profiling Market Size by Type (2016-2027)
9.3 Latin America Cancer Tumor Profiling Market Size by Application
9.3.1 Latin America Cancer Tumor Profiling Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Tumor Profiling Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Tumor Profiling Market Size by Application (2016-2027)
9.4 Latin America Cancer Tumor Profiling Market Size by Country
9.4.1 Latin America Cancer Tumor Profiling Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Tumor Profiling Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Tumor Profiling Market Size (2016-2027)
10.2 Middle East & Africa Cancer Tumor Profiling Market Size by Type
10.2.1 Middle East & Africa Cancer Tumor Profiling Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Tumor Profiling Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Tumor Profiling Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Tumor Profiling Market Size by Application
10.3.1 Middle East & Africa Cancer Tumor Profiling Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Tumor Profiling Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Tumor Profiling Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Tumor Profiling Market Size by Country
10.4.1 Middle East & Africa Cancer Tumor Profiling Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Tumor Profiling Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Qiagen N.V.
11.1.1 Qiagen N.V. Company Details
11.1.2 Qiagen N.V. Business Overview
11.1.3 Qiagen N.V. Cancer Tumor Profiling Introduction
11.1.4 Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2016-2021)
11.1.5 Qiagen N.V. Recent Development
11.2 Roche Molecular Systems Inc.
11.2.1 Roche Molecular Systems Inc. Company Details
11.2.2 Roche Molecular Systems Inc. Business Overview
11.2.3 Roche Molecular Systems Inc. Cancer Tumor Profiling Introduction
11.2.4 Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2016-2021)
11.2.5 Roche Molecular Systems Inc. Recent Development
11.3 Abott Molecular
11.3.1 Abott Molecular Company Details
11.3.2 Abott Molecular Business Overview
11.3.3 Abott Molecular Cancer Tumor Profiling Introduction
11.3.4 Abott Molecular Revenue in Cancer Tumor Profiling Business (2016-2021)
11.3.5 Abott Molecular Recent Development
11.4 Illumina Inc.
11.4.1 Illumina Inc. Company Details
11.4.2 Illumina Inc. Business Overview
11.4.3 Illumina Inc. Cancer Tumor Profiling Introduction
11.4.4 Illumina Inc. Revenue in Cancer Tumor Profiling Business (2016-2021)
11.4.5 Illumina Inc. Recent Development
11.5 NeoGenomics Laboratories
11.5.1 NeoGenomics Laboratories Company Details
11.5.2 NeoGenomics Laboratories Business Overview
11.5.3 NeoGenomics Laboratories Cancer Tumor Profiling Introduction
11.5.4 NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2016-2021)
11.5.5 NeoGenomics Laboratories Recent Development
11.6 HTG Molecular Diagnostic
11.6.1 HTG Molecular Diagnostic Company Details
11.6.2 HTG Molecular Diagnostic Business Overview
11.6.3 HTG Molecular Diagnostic Cancer Tumor Profiling Introduction
11.6.4 HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2016-2021)
11.6.5 HTG Molecular Diagnostic Recent Development
11.7 Genomic Health Inc.
11.7.1 Genomic Health Inc. Company Details
11.7.2 Genomic Health Inc. Business Overview
11.7.3 Genomic Health Inc. Cancer Tumor Profiling Introduction
11.7.4 Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2016-2021)
11.7.5 Genomic Health Inc. Recent Development
11.8 Hologic Gen-Probe
11.8.1 Hologic Gen-Probe Company Details
11.8.2 Hologic Gen-Probe Business Overview
11.8.3 Hologic Gen-Probe Cancer Tumor Profiling Introduction
11.8.4 Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2016-2021)
11.8.5 Hologic Gen-Probe Recent Development
11.9 BD Biosciences
11.9.1 BD Biosciences Company Details
11.9.2 BD Biosciences Business Overview
11.9.3 BD Biosciences Cancer Tumor Profiling Introduction
11.9.4 BD Biosciences Revenue in Cancer Tumor Profiling Business (2016-2021)
11.9.5 BD Biosciences Recent Development
11.10 Siemens Healthineers
11.10.1 Siemens Healthineers Company Details
11.10.2 Siemens Healthineers Business Overview
11.10.3 Siemens Healthineers Cancer Tumor Profiling Introduction
11.10.4 Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2016-2021)
11.10.5 Siemens Healthineers Recent Development
11.11 Claris Life Sciences
11.11.1 Claris Life Sciences Company Details
11.11.2 Claris Life Sciences Business Overview
11.11.3 Claris Life Sciences Cancer Tumor Profiling Introduction
11.11.4 Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2016-2021)
11.11.5 Claris Life Sciences Recent Development
11.12 Personal Genome Diagnostics, Inc.
11.12.1 Personal Genome Diagnostics, Inc. Company Details
11.12.2 Personal Genome Diagnostics, Inc. Business Overview
11.12.3 Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Introduction
11.12.4 Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2016-2021)
11.12.5 Personal Genome Diagnostics, Inc. Recent Development
11.13 Perthera, Inc.
11.13.1 Perthera, Inc. Company Details
11.13.2 Perthera, Inc. Business Overview
11.13.3 Perthera, Inc. Cancer Tumor Profiling Introduction
11.13.4 Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2016-2021)
11.13.5 Perthera, Inc. Recent Development
11.14 Foundation Medicine, Inc
11.14.1 Foundation Medicine, Inc Company Details
11.14.2 Foundation Medicine, Inc Business Overview
11.14.3 Foundation Medicine, Inc Cancer Tumor Profiling Introduction
11.14.4 Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2016-2021)
11.14.5 Foundation Medicine, Inc Recent Development
11.15 V., Strand
11.15.1 V., Strand Company Details
11.15.2 V., Strand Business Overview
11.15.3 V., Strand Cancer Tumor Profiling Introduction
11.15.4 V., Strand Revenue in Cancer Tumor Profiling Business (2016-2021)
11.15.5 V., Strand Recent Development
11.16 ApoCell
11.16.1 ApoCell Company Details
11.16.2 ApoCell Business Overview
11.16.3 ApoCell Cancer Tumor Profiling Introduction
11.16.4 ApoCell Revenue in Cancer Tumor Profiling Business (2016-2021)
11.16.5 ApoCell Recent Development
11.17 Contextual Genomics
11.17.1 Contextual Genomics Company Details
11.17.2 Contextual Genomics Business Overview
11.17.3 Contextual Genomics Cancer Tumor Profiling Introduction
11.17.4 Contextual Genomics Revenue in Cancer Tumor Profiling Business (2016-2021)
11.17.5 Contextual Genomics Recent Development
11.18 Agendia
11.18.1 Agendia Company Details
11.18.2 Agendia Business Overview
11.18.3 Agendia Cancer Tumor Profiling Introduction
11.18.4 Agendia Revenue in Cancer Tumor Profiling Business (2016-2021)
11.18.5 Agendia Recent Development
11.18 GenScript
.1 GenScript Company Details
.2 GenScript Business Overview
.3 GenScript Cancer Tumor Profiling Introduction
.4 GenScript Revenue in Cancer Tumor Profiling Business (2016-2021)
.5 GenScript Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Tumor Profiling Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Next-generation Sequencing (NGS)
Table 3. Key Players of Polymerase Chain Reaction (PCR)
Table 4. Key Players of Immunohistochemistry (IHC)
Table 5. Key Players of In Situ Hybridization (ISH)
Table 6. Key Players of Microarray
Table 7. Key Players of Others
Table 8. Global Cancer Tumor Profiling Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Cancer Tumor Profiling Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Cancer Tumor Profiling Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Cancer Tumor Profiling Market Share by Regions (2016-2021)
Table 12. Global Cancer Tumor Profiling Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Cancer Tumor Profiling Market Share by Regions (2022-2027)
Table 14. Cancer Tumor Profiling Market Trends
Table 15. Cancer Tumor Profiling Market Drivers
Table 16. Cancer Tumor Profiling Market Challenges
Table 17. Cancer Tumor Profiling Market Restraints
Table 18. Global Cancer Tumor Profiling Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Cancer Tumor Profiling Market Share by Players (2016-2021)
Table 20. Global Top Cancer Tumor Profiling Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Tumor Profiling as of 2020)
Table 21. Ranking of Global Top Cancer Tumor Profiling Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Cancer Tumor Profiling Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Cancer Tumor Profiling Product Solution and Service
Table 25. Date of Enter into Cancer Tumor Profiling Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cancer Tumor Profiling Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Cancer Tumor Profiling Revenue Market Share by Type (2016-2021)
Table 29. Global Cancer Tumor Profiling Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Cancer Tumor Profiling Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Cancer Tumor Profiling Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Cancer Tumor Profiling Revenue Market Share by Application (2016-2021)
Table 33. Global Cancer Tumor Profiling Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Cancer Tumor Profiling Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Cancer Tumor Profiling Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Cancer Tumor Profiling Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Cancer Tumor Profiling Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Cancer Tumor Profiling Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Cancer Tumor Profiling Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Cancer Tumor Profiling Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Cancer Tumor Profiling Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Cancer Tumor Profiling Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Cancer Tumor Profiling Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Cancer Tumor Profiling Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Cancer Tumor Profiling Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Cancer Tumor Profiling Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cancer Tumor Profiling Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cancer Tumor Profiling Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cancer Tumor Profiling Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Cancer Tumor Profiling Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Cancer Tumor Profiling Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Cancer Tumor Profiling Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Cancer Tumor Profiling Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Cancer Tumor Profiling Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Cancer Tumor Profiling Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Cancer Tumor Profiling Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Cancer Tumor Profiling Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Cancer Tumor Profiling Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cancer Tumor Profiling Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cancer Tumor Profiling Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cancer Tumor Profiling Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Cancer Tumor Profiling Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Cancer Tumor Profiling Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Cancer Tumor Profiling Market Size by Country (2022-2027) & (US$ Million)
Table 65. Qiagen N.V. Company Details
Table 66. Qiagen N.V. Business Overview
Table 67. Qiagen N.V. Cancer Tumor Profiling Product
Table 68. Qiagen N.V. Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 69. Qiagen N.V. Recent Development
Table 70. Roche Molecular Systems Inc. Company Details
Table 71. Roche Molecular Systems Inc. Business Overview
Table 72. Roche Molecular Systems Inc. Cancer Tumor Profiling Product
Table 73. Roche Molecular Systems Inc. Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 74. Roche Molecular Systems Inc. Recent Development
Table 75. Abott Molecular Company Details
Table 76. Abott Molecular Business Overview
Table 77. Abott Molecular Cancer Tumor Profiling Product
Table 78. Abott Molecular Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 79. Abott Molecular Recent Development
Table 80. Illumina Inc. Company Details
Table 81. Illumina Inc. Business Overview
Table 82. Illumina Inc. Cancer Tumor Profiling Product
Table 83. Illumina Inc. Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 84. Illumina Inc. Recent Development
Table 85. NeoGenomics Laboratories Company Details
Table 86. NeoGenomics Laboratories Business Overview
Table 87. NeoGenomics Laboratories Cancer Tumor Profiling Product
Table 88. NeoGenomics Laboratories Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 89. NeoGenomics Laboratories Recent Development
Table 90. HTG Molecular Diagnostic Company Details
Table 91. HTG Molecular Diagnostic Business Overview
Table 92. HTG Molecular Diagnostic Cancer Tumor Profiling Product
Table 93. HTG Molecular Diagnostic Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 94. HTG Molecular Diagnostic Recent Development
Table 95. Genomic Health Inc. Company Details
Table 96. Genomic Health Inc. Business Overview
Table 97. Genomic Health Inc. Cancer Tumor Profiling Product
Table 98. Genomic Health Inc. Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 99. Genomic Health Inc. Recent Development
Table 100. Hologic Gen-Probe Company Details
Table 101. Hologic Gen-Probe Business Overview
Table 102. Hologic Gen-Probe Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 103. Hologic Gen-Probe Recent Development
Table 104. BD Biosciences Company Details
Table 105. BD Biosciences Business Overview
Table 106. BD Biosciences Cancer Tumor Profiling Product
Table 107. BD Biosciences Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 108. BD Biosciences Recent Development
Table 109. Siemens Healthineers Company Details
Table 110. Siemens Healthineers Business Overview
Table 111. Siemens Healthineers Cancer Tumor Profiling Product
Table 112. Siemens Healthineers Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 113. Siemens Healthineers Recent Development
Table 114. Claris Life Sciences Company Details
Table 115. Claris Life Sciences Business Overview
Table 116. Claris Life Sciences Cancer Tumor Profiling Product
Table 117. Claris Life Sciences Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 118. Claris Life Sciences Recent Development
Table 119. Personal Genome Diagnostics, Inc. Company Details
Table 120. Personal Genome Diagnostics, Inc. Business Overview
Table 121. Personal Genome Diagnostics, Inc. Cancer Tumor Profiling Product
Table 122. Personal Genome Diagnostics, Inc. Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 123. Personal Genome Diagnostics, Inc. Recent Development
Table 124. Perthera, Inc. Company Details
Table 125. Perthera, Inc. Business Overview
Table 126. Perthera, Inc. Cancer Tumor Profiling Product
Table 127. Perthera, Inc. Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 128. Perthera, Inc. Recent Development
Table 129. Foundation Medicine, Inc Company Details
Table 130. Foundation Medicine, Inc Business Overview
Table 131. Foundation Medicine, Inc Cancer Tumor Profiling Product
Table 132. Foundation Medicine, Inc Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 133. Foundation Medicine, Inc Recent Development
Table 134. V., Strand Company Details
Table 135. V., Strand Business Overview
Table 136. V., Strand Cancer Tumor Profiling Product
Table 137. V., Strand Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 138. V., Strand Recent Development
Table 139. ApoCell Company Details
Table 140. ApoCell Business Overview
Table 141. ApoCell Cancer Tumor Profiling Product
Table 142. ApoCell Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 143. ApoCell Recent Development
Table 144. Contextual Genomics Company Details
Table 145. Contextual Genomics Business Overview
Table 146. Contextual Genomics Cancer Tumor Profiling Product
Table 147. Contextual Genomics Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 148. Contextual Genomics Recent Development
Table 149. Agendia Company Details
Table 150. Agendia Business Overview
Table 151. Agendia Cancer Tumor Profiling Product
Table 152. Agendia Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 153. Agendia Recent Development
Table 154. GenScript Company Details
Table 155. GenScript Business Overview
Table 156. GenScript Cancer Tumor Profiling Product
Table 157. GenScript Revenue in Cancer Tumor Profiling Business (2016-2021) & (US$ Million)
Table 158. GenScript Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Tumor Profiling Market Share by Type: 2020 VS 2027
Figure 2. Next-generation Sequencing (NGS) Features
Figure 3. Polymerase Chain Reaction (PCR) Features
Figure 4. Immunohistochemistry (IHC) Features
Figure 5. In Situ Hybridization (ISH) Features
Figure 6. Microarray Features
Figure 7. Others Features
Figure 8. Global Cancer Tumor Profiling Market Share by Application: 2020 VS 2027
Figure 9. Personalized Medicine Case Studies
Figure 10. Diagnostics Case Studies
Figure 11. Biomarker Discovery Case Studies
Figure 12. Prognostics Case Studies
Figure 13. Research Applications Case Studies
Figure 14. Cancer Tumor Profiling Report Years Considered
Figure 15. Global Cancer Tumor Profiling Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Cancer Tumor Profiling Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Cancer Tumor Profiling Market Share by Regions: 2020 VS 2027
Figure 18. Global Cancer Tumor Profiling Market Share by Regions (2022-2027)
Figure 19. Global Cancer Tumor Profiling Market Share by Players in 2020
Figure 20. Global Top Cancer Tumor Profiling Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Tumor Profiling as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Cancer Tumor Profiling Revenue in 2020
Figure 22. Global Cancer Tumor Profiling Revenue Market Share by Type (2016-2021)
Figure 23. Global Cancer Tumor Profiling Revenue Market Share by Type (2022-2027)
Figure 24. North America Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Cancer Tumor Profiling Market Share by Type (2016-2027)
Figure 26. North America Cancer Tumor Profiling Market Share by Application (2016-2027)
Figure 27. North America Cancer Tumor Profiling Market Share by Country (2016-2027)
Figure 28. United States Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Cancer Tumor Profiling Market Share by Type (2016-2027)
Figure 32. Europe Cancer Tumor Profiling Market Share by Application (2016-2027)
Figure 33. Europe Cancer Tumor Profiling Market Share by Country (2016-2027)
Figure 34. Germany Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Cancer Tumor Profiling Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Cancer Tumor Profiling Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Cancer Tumor Profiling Market Share by Region (2016-2027)
Figure 44. China Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Cancer Tumor Profiling Market Share by Type (2016-2027)
Figure 52. Latin America Cancer Tumor Profiling Market Share by Application (2016-2027)
Figure 53. Latin America Cancer Tumor Profiling Market Share by Country (2016-2027)
Figure 54. Mexico Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Cancer Tumor Profiling Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Cancer Tumor Profiling Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Cancer Tumor Profiling Market Share by Country (2016-2027)
Figure 60. Turkey Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Cancer Tumor Profiling Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Qiagen N.V. Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 64. Roche Molecular Systems Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 65. Abott Molecular Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 66. Illumina Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 67. NeoGenomics Laboratories Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 68. HTG Molecular Diagnostic Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 69. Genomic Health Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 70. Hologic Gen-Probe Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 71. BD Biosciences Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 72. Siemens Healthineers Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 73. Claris Life Sciences Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 74. Personal Genome Diagnostics, Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 75. Perthera, Inc. Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 76. Foundation Medicine, Inc Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 77. V., Strand Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 78. ApoCell Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 79. Contextual Genomics Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 80. Agendia Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 81. GenScript Revenue Growth Rate in Cancer Tumor Profiling Business (2016-2021)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
世界の個別化がん医療市場規模・現状・予測（2021年-2027年） Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don’t. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors c…- 世界の固形腫瘍がん治療市場規模・現状・予測（2021年-2027年） An abnormal mass of tissue that usually does not contain cysts or liquid areas. Market Analysis and Insights: Global Solid Tumor Cancer Treatment Market The global Solid Tumor Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% dur…
- 世界の遺伝子発現プロファイリング分析市場規模・現状・予測（2021年-2027年） Gene expression profiling is the measurement of the activity (the expression) of thousands of genes at once, to create a global picture of cellular function. These profiles can, for example, distinguish between cells that are actively dividing, or show how the cells react to a particular treatment. …
- 世界の消化管間質腫瘍分子診断市場規模・現状・予測（2021年-2027年） A method for diagnosing gastrointestinal Stromal Tumor Market Analysis and Insights: Global Gastrointestinal Stromal Tumor Molecular Diagnostics Market The global Gastrointestinal Stromal Tumor Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 202…
- 世界の個別化がんワクチン市場規模・現状・予測（2021年-2027年） Personalized Cancer Vaccines are the type of immunotherapy that boosts the immune system to fight against a cancerous cell. These types of vaccine are tailored to match a patient’s particular tumor cell after received cancer related surgery. This vaccine may prevent from cancer, destroy cancer cells…